-
-
-
-
-
-
-
Edwards Lifesciences provides 2026 financial guidance at investor conference
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Edwards Lifesciences (EW)
-
-
-
-
-
-
-
EW DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation Investors of Deadline and Encourages Investors with Losses to Contact the Firm
-
-
-
-
-
-
-
Edwards Lifesciences (EW) PT Lowered to $71 at Truist Securities
-
-
-
-
-
-
-
Edwards Lifesciences to Acquire Innovalve
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/21: (OCGN) (WBT) (ISRG) Higher; (DGLY) (NFLX) (ROKU) Lower (more...)
-
-
-
-
-
-
-
Edwards Lifesciences Reports Fourth Quarter Results
-
1,161,626 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

